Agreement - February 16, 2026
Ribocure in global licensing agreement
Suzhou Ribo Life Science and its Swedish subsidiary Ribocure Pharmaceuticals have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Careers article - February 15, 2026
Corporate storytelling – Populate your trademark with reality
The method of storytelling has been an excellent way to spread information, knowledge and experiences for centuries.
Business article - February 12, 2026
New coalition aims to strengthen Europe’s life science investment ecosystem
The European Life Sciences Coalition (ELSC) aims to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector.
Acquisition - February 12, 2026
Devyser acquires Cybergene
Devyser Diagnostics has entered into an agreement relating to the acquisition of 100 percent of the shares in Cybergene AB, a Swedish company within the Level Bio group.
Science Award - February 12, 2026
He is the winner of the Sjöberg Prize
This year’s Sjöberg Prize of one million US dollars is awarded to a British cancer researcher who has provided fundamental knowledge about evolution in tumours.
Biotech Business - February 11, 2026
Neogap secures SEK 87 million to advance its personalized immunotherapy
The financing round was led by Sciety and the capital will be used to advance the company’s ongoing clinical study and to build the data required for the next stage of its development programme.
